Aileron Therapeutics, a Cambridge, Mass.–based developer of cell-permeable peptide technology to help treat cancer, announced that it has raised $10 million in Series C funding. The round closed late last year, and was co-led by Apple Tree Partners and the Novartis Venture. Read more...
QD Vision Inc., a Watertown, Mass.-based nanotech product company focused on the display and lighting markets, has called down $9 million of a $16 million Series C round, according to a regulatory filing. Return backers include Highland Capital Partners and North Bridge Venture Partners, while the company's website also lists In-Q-Tel and OSI Ventures as investors. www.qdvision.com
Boston, Mass.
User Manual Co. OwnerIQ Brings Badeau Into Fold
OwnerIQ Inc., a company that helps consumers find user manuals online, has appointed Lisa Badeau to its board of directors.
http://owneriq.net
User Manual Co. OwnerIQ Brings Badeau Into Fold
OwnerIQ Inc., a company that helps consumers find user manuals online, has appointed Lisa Badeau to its board of directors.
http://owneriq.net
Highland Capital mentions (may well be repeats of prior listings):
Hangout.net, Boston, 3D social networking.
Old Road Computing, Westford, Management of mobile devices on enterprice networks.
Streambase, Lex. processing technology for streaming real time systems.
Cambridge, Mass.
Aileron Rolls Up $10M For Research Facility
Biopharmaceutical company Aileron Therapeutics Inc. has raised a $10 million Series C round to expand its team and open a new research facility.
http://www.aileronrx.com
Aileron Rolls Up $10M For Research Facility
Biopharmaceutical company Aileron Therapeutics Inc. has raised a $10 million Series C round to expand its team and open a new research facility.
http://www.aileronrx.com
Drug Therapies | Boston
Trial Results Trigger Final Close For Paratek's Series H
Biopharmaceutical company Paratek Pharmaceuticals Inc. has closed the second and final tranche of its $40 million Series H round after receiving positive Phase II results for its lead treatment.
http://www.paratekpharm.com
Drug Research | Waltham, Mass.
Dynogen Scratches SPAC Merger, Seeks VC
Dynogen Pharmaceuticals Inc. has terminated its planned merger with a special purpose acquisition company and will instead look to raise new venture financing this year.
http://www.dynogen.com
Trial Results Trigger Final Close For Paratek's Series H
Biopharmaceutical company Paratek Pharmaceuticals Inc. has closed the second and final tranche of its $40 million Series H round after receiving positive Phase II results for its lead treatment.
http://www.paratekpharm.com
Drug Research | Waltham, Mass.
Dynogen Scratches SPAC Merger, Seeks VC
Dynogen Pharmaceuticals Inc. has terminated its planned merger with a special purpose acquisition company and will instead look to raise new venture financing this year.
http://www.dynogen.com
GamerDNA Inc. (f.k.a. GuildCafe), a Cambridge, Mass.-based social media site for online gamers, has raised $3 million in Series A funding led by Flybridge Capital Partners. The company also raised an undisclosed amount of seed funding from Flybridge last summer. Read more…
Cambridge, Mass.
Stromedix Gathers $25M For Fibrosis Drug
With an eye on tackling the wide range of diseases caused by fibrosis, Stromedix Inc. has raised $25 million in Series B funding to advance its lead compound further into the clinic.
http://www.stromedix.com
Imaging Equipment | Woburn, Mass.
VisEn Reopens Series B For $5M More
With a busy rollout of products planned for the year, VisEn Medical Inc. has tapped its existing investors for an additional $5 million in Series B funding, bringing the round to $12 million.
http://www.visenmedical.com
Stromedix Gathers $25M For Fibrosis Drug
With an eye on tackling the wide range of diseases caused by fibrosis, Stromedix Inc. has raised $25 million in Series B funding to advance its lead compound further into the clinic.
http://www.stromedix.com
Imaging Equipment | Woburn, Mass.
VisEn Reopens Series B For $5M More
With a busy rollout of products planned for the year, VisEn Medical Inc. has tapped its existing investors for an additional $5 million in Series B funding, bringing the round to $12 million.
http://www.visenmedical.com
Be a better friend, newshound, and know-it-all with Yahoo! Mobile. Try it now.
